Consumer News

March 30, 2017

FDA Approves New Multiple Sclerosis Drug

The Food and Drug Administration (FDA) has approved Genentech’s new drug Ocrevus, which is the first approved treatment available for primary progressive multiple sclerosis (MS).

Follow Us

Subscribe

Sign up for updates on the latest consumer news